1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits to the stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. DIGITAL THERAPEUTICS MARKET BY TYPE
5.1. Introduction
5.2. Devices
5.2.1. Market opportunities and trends
5.2.2. Growth prospects
5.2.3. Geographic lucrativeness
5.3. Software & Services
5.3.1. Market opportunities and trends
5.3.2. Growth prospects
5.3.3. Geographic lucrativeness
6. DIGITAL THERAPEUTICS MARKET BY APPLICATION
6.1. Introduction
6.2. Diabetes
6.2.1. Market opportunities and trends
6.2.2. Growth prospects
6.2.3. Geographic lucrativeness
6.3. Obesity
6.3.1. Market opportunities and trends
6.3.2. Growth prospects
6.3.3. Geographic lucrativeness
6.4. CVD
6.4.1. Market opportunities and trends
6.4.2. Growth prospects
6.4.3. Geographic lucrativeness
6.5. Respiratory Diseases
6.5.1. Market opportunities and trends
6.5.2. Growth prospects
6.5.3. Geographic lucrativeness
6.6. Smoking Cessation
6.6.1. Market opportunities and trends
6.6.2. Growth prospects
6.6.3. Geographic lucrativeness
6.7. CNS Diseases
6.7.1. Market opportunities and trends
6.7.2. Growth prospects
6.7.3. Geographic lucrativeness
6.8. Others
6.8.1. Market opportunities and trends
6.8.2. Growth prospects
6.8.3. Geographic lucrativeness
7. DIGITAL THERAPEUTICS MARKET BY END-USER
7.1. Introduction
7.2. Patients
7.2.1. Market opportunities and trends
7.2.2. Growth prospects
7.2.3. Geographic lucrativeness
7.3. Providers
7.3.1. Market opportunities and trends
7.3.2. Growth prospects
7.3.3. Geographic lucrativeness
7.4. Payers
7.4.1. Market opportunities and trends
7.4.2. Growth prospects
7.4.3. Geographic lucrativeness
7.5. Employers
7.5.1. Market opportunities and trends
7.5.2. Growth prospects
7.5.3. Geographic lucrativeness
7.6. Others
7.6.1. Market opportunities and trends
7.6.2. Growth prospects
7.6.3. Geographic lucrativeness
8. DIGITAL THERAPEUTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.1.1. Market Trends and Opportunities
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Trends and Opportunities
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Trends and Opportunities
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Type
8.3.2. By Application
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Trends and Opportunities
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Trends and Opportunities
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Trends and Opportunities
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Type
8.4.2. By Application
8.4.3. By End-User
8.4.4. By Deployment
8.4.5. By End-user
8.4.6. By Country
8.4.6.1. Germany
8.4.6.1.1. Market Trends and Opportunities
8.4.6.1.2. Growth Prospects
8.4.6.2. France
8.4.6.2.1. Market Trends and Opportunities
8.4.6.2.2. Growth Prospects
8.4.6.3. UK
8.4.6.3.1. Market Trends and Opportunities
8.4.6.3.2. Growth Prospects
8.4.6.4. Spain
8.4.6.4.1. Market Trends and Opportunities
8.4.6.4.2. Growth Prospects
8.4.6.5. Others
8.4.6.5.1. Market Trends and Opportunities
8.4.6.5.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Application
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Trends and Opportunities
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Trends and Opportunities
8.5.4.2.2. Growth Prospects
8.5.4.3. Israel
8.5.4.3.1. Market Trends and Opportunities
8.5.4.3.2. Growth Prospects
8.5.4.4. Others
8.5.4.4.1. Market Trends and Opportunities
8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Application
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Trends and Opportunities
8.6.4.1.2. Growth Prospects
8.6.4.2. Japan
8.6.4.2.1. Market Trends and Opportunities
8.6.4.2.2. Growth Prospects
8.6.4.3. India
8.6.4.3.1. Market Trends and Opportunities
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Trends and Opportunities
8.6.4.4.2. Growth Prospects
8.6.4.5. Indonesia
8.6.4.5.1. Market Trends and Opportunities
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Trends and Opportunities
8.6.4.6.2. Growth Prospects
8.6.4.7. Others
8.6.4.7.1. Market Trends and Opportunities
8.6.4.7.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisition, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Omada Health, Inc.
10.2. Welldoc, Inc.
10.3. 2Morrow, Inc
10.4. Livongo Health, Inc. (Teladoc Health, Inc.)
10.5. Propeller Health (ResMed)
10.6. Fitbit LLC
10.7. CANARY HEALTH
10.8. Noom, Inc.
10.9. Akili Interactive Labs, Inc.